chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the patient. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HORMONE LEVEL ABNORMAL (non-serious), outcome "unknown", described as "Covid vaccine has screwed up my hormones". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Case Category: Patient Assistance Programs.  The patient reported to Pfizer.com Description of Inquiry: Have you figured out why your Covid vaccine has screwed up my hormones yet because its annoying. CEP Number: CEP 005570. The information on the batch/lot number for (BNT162B2), has been requested and will be submitted if and when received. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I was having extreme difficulty walking for a week. Wobbly legs (muscle and nerve impairment) severe fatigue and weakness. Vestibular dysfunction and Auditory issues.  I suspect a Guillain-Barre type immune system  response to second injection? I verified this on CDC website. I am trying to get in to a neurologist ( 3 month wait)  My Primary   care Dr. is aware of issues. Original response was to give it time. I have started PT as of 6-8-21. I need to have a Neurologist  investigate and I believe doing an NCV test will "reset"{ the nerves. This worked several years ago after neck surgery issues.
Information has been received from a physician concerning a 60 year old female with allergies to codeine, DEMEROL, anti-inflammatory agents, OMNICEF and doxycycline who on 12-JUL-2008 was vaccinated with the first dose of ZOSTAVAX. On 12-JUL-2008, the patient experienced redness at the injection. On 16-JUL-2008, the patient experienced a sore on lip. The sore on her lip was either herpes simplex or poison ivy. The physician examined the patient on 16-JUL-2008. The patient's redness at the injection and sore on lip persisted. It was also reported the patient experienced right upper arm erythema and edema with no vesicles. The size was 10 cm-28cm. There was no vesicle on upper lip. Additional information has been requested. On 03-Oct-2008, the patient recovered from the events, no redness and no scar reported. Additional information is not expected.
Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032321a and 027a21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.).   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced CHEST PAIN (Chest pain). On 16-Apr-2021, CHEST PAIN (Chest pain) had resolved.            For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments  Concomitant product use was not provided.   Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in response to the event is not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Five weeks after my booster I broke out in Shingles on the right side upper chest area of my body. Then had some slight spotting on my upper back. Three days later on 01/25/2022 I went back to the same Clinic where I got the booster and I was diagnosed with Shingles. I was given Valtrex 1000mg twice a day for 1 week.
-Itchy, red rash over entire body lasting from approximately 2/28/21 to 3/17/21.
crying, difficult to console, high pitched screaming;onset later the same day lasting until evening of 11FEB99;
Tested positive for COVID- om 12/30/2022 I had mild symptoms . However I have had an ongoing issue with Cellulitis and was admitted for 3 days and given IV antibiotics.
Patient had reaction to COVID-19 vaccine. Patient was monitored after COVID-19 vaccine as recommended per ACIP guidelines.    The following reaction signs/symptoms were observed: syncope, vomitting   Emergency response notified:  EMS (911)   EpiPen administered by RN as per JH standing order?:  No   Required VAERS reporting completed?: No   Report given to EMS (911)   Patient was given vaccine at 0918, immediately flagged for nurse at 0920. Nurse went to patient and obtained vitals.   BP 150/80 HR 56 regular SP02 99% R 18 regular   Called EMS, patient was given water and emesis bag.   Vital taken again: BP 130/70 HR 60 regular   EMS evaluated patient and stayed 10 mins, advised of nurse hotline on COVID packet & further medical evaluation. Patient was then release to go home.
Information has been received from a physician concerning an 18 year old female who on 13-AUG-2007 was vaccinated intramuscularly with a second dose of Gardasil (lot#65822/0927U). On 13-AUG-2007 the patient described the vaccine as being "very painful." The patient did not seek medical attention. On 13-AUG-2007 the patient recovered before leaving the physician's office. Additional information has been requested.
Caused severe swelling , and pain in my arm pit on the right side where the shot was administered.
muscle ache, fatigue, sore throat, sinus, fever, chills, breathing issues, headache, sense of smell, exhausted, heart palpitations
The day after my vaccination I started to have muscle aches on my legs and glutes. Specifically just the lower body that had the muscle aches. These muscle aches only lasted for around 8 hours and then went away. I did have some fatigue as well. The next day I felt completely normal. I did come down with COVID-19 08/14/2022, I was 37 weeks pregnant. I had congested nose, sore throat, pain in my ears and the sore throat got worse and I developed a cough. The cough lasted for 4 weeks. Symptoms lasted for 2 weeks. I am now feeling well.
Couldn't sleep/she was not able to sleep at all; Hips were in tremendous pain/Sunday (9OCT2022) night it became worse; This spontaneous case was reported by a patient and describes the occurrence of INSOMNIA (Couldn't sleep/she was not able to sleep at all) and ARTHRALGIA (Hips were in tremendous pain/Sunday (9OCT2022) night it became worse) in an 83-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7163B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer vaccine (Dose 1), Pfizer vaccine (Booster 2), Pfizer vaccine (Booster 1) and Pfizer vaccine (Dose 2). Past adverse reactions to the above products included No adverse event with Pfizer vaccine, Pfizer vaccine, Pfizer vaccine and Pfizer vaccine.    On 07-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 07-Oct-2022, the patient experienced INSOMNIA (Couldn't sleep/she was not able to sleep at all) and ARTHRALGIA (Hips were in tremendous pain/Sunday (9OCT2022) night it became worse). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INSOMNIA (Couldn't sleep/she was not able to sleep at all) and ARTHRALGIA (Hips were in tremendous pain/Sunday (9OCT2022) night it became worse) had not resolved.            The concomitant medication was not reported by reporter.  It was reported that on that night both of patient's hips were in tremendous pain and could not sleep. On 08-Oct-2022, (Saturday) the pain became lesser, and patient thought it was going away. On 09-Oct-2022 (Sunday) night it became worse, and patient was not able to sleep at all. Patient took Tylenol to help with her symptoms, however patient continued to be unable to sleep.
upset stomach; headaches off and on; Dizziness; tiredness; This case was reported by a consumer via call center representative and described the occurrence of upset stomach in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included macular degeneration (has macular degeneration that could caused weird ocular effects) and heart disorder.   On 1st October 2021, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a month after receiving Shingrix, the patient experienced upset stomach, headache, dizziness and tiredness. On an unknown date, the outcome of the upset stomach was recovered/resolved and the outcome of the headache, dizziness and tiredness were not recovered/not resolved.   The reporter considered the upset stomach to be unrelated to Shingrix. It was unknown if the reporter considered the headache, dizziness and tiredness to be related to Shingrix.  Additional details were provided are as follows: The patient received a shot of Shingrix and had disturbing dizziness off and on, headache off and on, but thought they were related to the dizziness. The patient was unsure if the dizziness was related to the vaccine as she also has had macular degeneration that can cause weird ocular effects and stated that she was also experiencing tiredness, but thought this was more related to her heart issues and lifestyle. The patient also had an upset stomach post vaccine. The patient was unsure exactly when these symptoms started post vaccine. Medical information number to her health care professional. Spoken as per content and gave medical disclaimer. The patient stated she was going to follow-up with her health care professional. No health care professional provided. The reporter did not consented to follow-up.
vomiting; feeling awful; shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting), VACCINATION COMPLICATION (feeling awful) and DYSPNOEA (shortness of breath) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K2OA) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (vomiting), VACCINATION COMPLICATION (feeling awful) and DYSPNOEA (shortness of breath). At the time of the report, VOMITING (vomiting), VACCINATION COMPLICATION (feeling awful) and DYSPNOEA (shortness of breath) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient had syncopal episode with out loss of consciousness. Patient became diaphoretic with a palpable irregular heart rate. He was closely observed and placed in a laying position with his feet elevated. Biox was 99% with an irregular HR of 78. Patient recovered to his baseline in approximately 45 minutes and left the facility with his driver and recommendations to follow up with urgent care and to contact his healthcare provider.
High fevers intractable to Tylenol or Advil x 48 hours, greater than 103.2 Long-standing rash developed on torso on day 3, ~ 72 hours.  Rash continues now as well.
On 12/23/21 I had chills and body aches, on 12/24/21 started with chest pain, thought it was heartburn,  then on 12/25/21 i went to emergency room  with chest pain, vomitting, pain in jaw and arms. I was admitted. the diagnosis was myocarditis. was advised to report the findings.
Heart racing; Dizziness; Bad muscle aches; Fatigue; Felt absolutely terrible; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 26Mar2021 at 13:30 (at the age of 50-years-old) as a dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 26Mar2021 at 13:45, the patient reported that she had bad side effects which included heart racing, dizziness initially and then bad muscle aches, fatigue; the patient felt absolutely terrible for the next 3 days. Since the vaccination, the patient had not been tested for COVID-19. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcomes of the events heart racing, dizziness initially, bad muscle aches, fatigue and felt absolutely terrible were resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Mild headache; Soreness at injection site; This is a spontaneous report from a non-contactable consumer (the patient).  A patient of unspecified age and gender received  BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number and expiration date unknown), via an unknown route of administration, on an unknown date (at an unknown age) as a single dose for COVID-19 vaccination.  Medical history was not reported. The patient's concomitant medications were not reported.  On an unspecified date the patient experienced mild headache and soreness at the injection site. The clinical outcomes of mild headache and soreness at the injection site was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Per patient she reported the following side effects and timeframe.  Patient states she felt tired the afternoon after her vaccine, by the evening she started to develop a headache, that worsened throughout the night. Patient denies having any side effects or reaction during her 15 minute post vaccine administration observation time.  48 hours from the time of the  injection, patient noticed a "red" spot on her arm and headache continued. That following Monday, patient states she had a fever and the injection site was hot to the touch and painful.  Patient was seen by her PCP, per patient was told by her PCP she had an infection at the injection site due to bacteria. She was prescribed medication for the infection.    That following Thursday, patient states she noticed swelling in her injection arm.  Per patient she was seen by her PCP and given an "injection for the swelling".   Patient states she is on her last day of antibiotic treatment, symptoms have improved and has a follow-up appointment with her PCP.
Received the first dose of the Moderna COVID19 vaccine being 16,5 years old on march; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the first dose of the Moderna COVID19 vaccine being 16,5 years old on march) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the first dose of the Moderna COVID19 vaccine being 16,5 years old on march). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the first dose of the Moderna COVID19 vaccine being 16,5 years old on march) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    Concomitant medication was not reported. Treatment information not reported.
pt recv vax 10DEC93 & 25DEC93 devel backache, neck pain, shoulder pain, lower back pain, rt leg pain, stomach pain, cramps & occasional lightheadedness; also had malaise; ultrasound revealed ovarian cyst; exp tenderness over rt sacroiliac
pt recvd vax;devel full blown hives on most of his body w/ swelling of eyes & lips;to er & was tx w/ unspecified injectable med;several hrs later upon returning home,hives became full blown again;tx w/ hydroxyzine;
Pt has received influenza vaccination in the past but not PNEUMOVAX 23. Pt was unable to get the vaccine in the left arm due to lymph node removal. Pt developed a swollen arm that was hot to the touch. Saw her physician and was prescribed KEFLEX and MEDROL DOSE PAK.
This spontaneous report has been received from a registered nurse refers to an 11 year old female patient. The patient had no pertinent medical history or drug allergies. On 01-OCT-2007, the patient was vaccinated with the first dose of GARDASIL injection (strength and dose not reported, lot # reported as 10614, expiration date: 14-APR-2010), intramuscularly. The patient had no concomitant therapies. On the same date, after receiving that vaccination, the patient fainted in the office and hit her head on a door jam which resulting in a contact seizure. No treatment was given. No labs were performed. The patient was taken back to a room, observed, recovered quickly and sent back home within 15 minutes. On 13-JAN-2015 the patient was vaccinated with the second dose of GARDASIL (strength, dose, route and lot # not reported), with no reported concerns. Lot number 10614 is an invalid lot number for GARDASIL. Upon internal review, contact seizure was considered to be medically significant. Additional information has been requested.
Patient became red and blotchy, trouble breathing and trouble with speech.  Patient received O2.  Patient was watched in the office for 1 hour.
2 weeks (+/-) after pain in left hip, as if I had fallen on the ice, and landed on my hip.
urticaria over total body;mild resp distress-no wheezing;tight feeling throat;
Patient complained from spasm to his throat and right check around 9:10 pm 2-13-2018. R.ph injected him with BENADRYL 50 mg IM.
After a minute starting having issues with breathing stomach pain and dizziness. Broke out with rash store nurse gave my daughter Benadryl and we waited about 20 minutes she started to feel better and the symptoms went away.
devel t105 6 hrs p/vax; cult neg; elevated WBC; vomited several times next AM;
Reactions created stiffness in neck, no balance, vertigo, dizziness, tingling/numbness in both left and right hand and both feet. Headaches, blurry vision and extreme increased dizziness when laying down. Extreme no balance, frequent urination. Was given the same shot in March 1991. Same symptoms occurred and continued for a 10 year period.
Received a third Moderna dose of 0.5 ml instead of the booster of 0.25 ml; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Received a third Moderna dose of 0.5 ml instead of the booster of 0.25 ml) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 24-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (Received a third Moderna dose of 0.5 ml instead of the booster of 0.25 ml). On 24-Oct-2021, ACCIDENTAL OVERDOSE (Received a third Moderna dose of 0.5 ml instead of the booster of 0.25 ml) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was reported.
Approx 1 week after receiving injection, developed itching and "pink rash" at site of injection.
Fever, bulging fontanel occurred within 24 hours post vaccine administration, baby was admitted to the Hospital.
Information has been received from a physician and an advanced practice nurse concerning a male over 50 years old with diabetes, who on approximately 28-AUG-2008 was vaccinated with a dose of PNEUMOVAX. On 28-AUG-2008 later in the day the patient developed severe edema and swelling at the injection site and the arm. It was reported that the patient had been hospitalized over the past few years for unspecified conditions and may have previously received a dose of PNEUMOVAX during that time. The patient sought unspecified medical attention. No laboratory diagnostics were performed. The patient recovered on an unspecified date. No product quality complaint was involved. Follow-up information has been received from medical records and an advanced practice nurse who reported that the 55 year old disabled male (previously reported as 50 year old), with allergy to steroids, ULTRAM, PHENERGAN, ACTOS and celucophage (therapy unspecified) was vaccinated on 10-SEP-2008 with a dose of PNEUMOVAX, 0.5 mL, in the left deltoid in the morning. This date, the patient experienced left extremity tender to touch, warm to touch, weakness, not able to raise without pain or discomfort, discomfort in neck, shoulder and in arm, headache, he felt lousy and chills fever. The patient sought medical attention. On 11-SEP-2008, were performed some labs and the relevant results were: serum sodium test: low; anion gap: low, serum glucose test: high; urine microalbumin test, high; seg manual: high; urine glucose test: negative : white blood cell count:high; seg: high; blood monocyte count: high; blood lymphocyte count: low; mean corpuscular hemoglobin concentration: high; blood in urine: trace A; erythrocyte sedimentation rate: high; blood lymphocyte count: high and serum high-density lipoprotein cholesterol test: low. On 12-SEP-2008, a left upper extremity venous doppler evaluation was performed which showed no evidence of DVT. On 16-SEP-2008, the patient recovered. No additional information is expected.
Hashimoto's disease; high blood pressure; osteoporosis; This is a spontaneous report from a contactable consumer.   A 77-year-old female patient received the first dose of  BNT162B2, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunization.  The patient medical history and concomitant medications were not reported.  The patient experienced Hashimoto's disease, high blood pressure, and osteoporosis on an unspecified date. The outcome of events was unknown.   The event occurred in a country different from that of the reporter. This may be a duplicate report if another reporter from the country where the event occurred has submitted the same information to his/her local agency.  The information about lot number and expiration date has been requested